UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation

Journal of clinical oncology, 1988-04, Vol.6 (4), p.669-678

1988

Volltextzugriff (PDF)

Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs

Biology of the neonate, 2000, Vol.77 (1), p.50-57

2000

Volltextzugriff (PDF)

Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 1994-03, Vol.13 (3), p.311-316

1994

Volltextzugriff (PDF)

Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains

Human gene therapy, 2007-08, Vol.18 (8), p.712-725

2007

Volltextzugriff (PDF)

Interleukin-12 induced cytolytic activity in lymphocytes from recipients of autologous and allogeneic stem cell transplants

Bone marrow transplantation (Basingstoke), 1997-05, Vol.19 (9), p.867-873

1997

Volltextzugriff (PDF)

Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma

Journal of clinical oncology, 1992-06, Vol.10 (6), p.960-968

1992

Volltextzugriff (PDF)

Enteral feeding in infants <1250 g starting within 24 h post-partum

European journal of pediatrics, 2001-10, Vol.160 (10), p.629-632

2001

Volltextzugriff (PDF)

Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells

Cancer research (Chicago, Ill.), 1989, Vol.49 (1), p.235-240

1989

Volltextzugriff (PDF)

Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial

Cancer research (Chicago, Ill.), 1987-08, Vol.47 (15), p.4202-4207

1987

Volltextzugriff (PDF)

Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy

Experimental hematology, 1993-09, Vol.21 (10), p.1371-1378

1993

Volltextzugriff (PDF)

Pentoxifylline Inhibits Integrin-Mediated Adherence of Interleukin-2–Activated Human Peripheral Blood Lymphocytes to Human Umbilical Vein Endothelial Cells, Matrix Components, and Cultured Tumor Cells

Blood, 1994-10, Vol.84 (7), p.2234-2242

1994

Volltextzugriff (PDF)

Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4

Journal of immunotherapy (1997), 1993-11, Vol.14 (4), p.322-328

1993

Volltextzugriff (PDF)

Cellular Immunotherapy for Follicular Lymphoma Using Genetically Modified CD20-Specific CD8+ Cytotoxic T Lymphocytes

Molecular therapy, 2004-04, Vol.9 (4), p.577-586

2004

Volltextzugriff (PDF)

Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies

Cancer research (Chicago, Ill.), 1989-10, Vol.49 (20), p.5509-5513

1989

Volltextzugriff (PDF)

GMP Documentation

Cell Therapy, p.389-402

Volltextzugriff (PDF)

Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro

Cancer research (Chicago, Ill.), 1989-12, Vol.49 (23), p.6487-6492

1989

Volltextzugriff (PDF)

Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients

Cancer research (Chicago, Ill.), 1990-02, Vol.50 (4), p.1160-1164

1990

Volltextzugriff (PDF)

Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects

Cancer Immunology Immunotherapy, 1987-07, Vol.25 (1), p.47-53

1987

Volltextzugriff (PDF)

The effects of pentoxifylline on the generation of human lymphokine-activated killer cell cytotoxicity

Journal of immunotherapy (1997), 1993-02, Vol.13 (2), p.84-90

1993

Volltextzugriff (PDF)

Impaired in vivo and in vitro antibody responses to bacteriophage phi X 174 in juvenile rheumatoid arthritis

Journal of rheumatology, 1987-10, Vol.14 (5), p.957

1987

Volltextzugriff (PDF)

Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma

The cancer journal from Scientific American, 1997-12, Vol.3 Suppl 1, p.S29

1997

Volltextzugriff (PDF)

Prolonged continous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma

Journal of clinical oncology, 1992, Vol.10 (6), p.960-968

1992

Volltextzugriff (PDF)

Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells

Blood, 1994-10, Vol.84 (7), p.2234-2242

1994

Volltextzugriff (PDF)

Outcome after acute ischemic stroke is linked to sex-specific lesion patterns

Nature communications, 2021-06, Vol.12 (1), p.3289-3289, Article 3289

2021

Volltextzugriff (PDF)

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

Nature communications, 2018-12, Vol.9 (1), p.5150-13, Article 5150

2018

Volltextzugriff (PDF)

1 – 25 von 1.081

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(934)
Mit Volltextzugriff
(897)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(597)
Life Sciences & Biomedicine
(420)
Humans
(396)
Female
(244)
Medicin Och Hälsovetenskap
(232)
Male
(224)
Biological And Medical Sciences
(186)
Physics
(169)
Medical Sciences
(155)
Physical Sciences
(146)
Middle Aged
(144)
Adult
(142)
Aged
(96)
Medical And Health Sciences
(93)
Clinical Medicine
(76)
Klinisk Medicin
(76)
Genetics & Heredity
(67)
Risk Factors
(67)
Physics Of Elementary Particles And Fields
(63)
Neurosciences & Neurology
(62)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Influence of dose and duration of infusion of interleukin-2 on toxicity and immunomodulation

Influence of mild hypothermia after hypoxia-ischemia on the pharmacokinetics of gentamicin in newborn pigs

Lymphokine-activated killer (LAK) precursor cell activity is present in infused peripheral blood stem cells and in the blood after autologous peripheral blood stem cell transplantation

Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains

Interleukin-12 induced cytolytic activity in lymphocytes from recipients of autologous and allogeneic stem cell transplants

Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma

Enteral feeding in infants <1250 g starting within 24 h post-partum

Influence of schedule of interleukin 2 administration on therapy with interleukin 2 and lymphokine activated killer cells

Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial

Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy

Pentoxifylline Inhibits Integrin-Mediated Adherence of Interleukin-2–Activated Human Peripheral Blood Lymphocytes to Human Umbilical Vein Endothelial Cells, Matrix Components, and Cultured Tumor Cells

Growth and autologous tumor lysis by tumor-infiltrating lymphocytes from metastatic melanoma expanded in interleukin-2 or interleukin-2 plus interleukin-4

Cellular Immunotherapy for Follicular Lymphoma Using Genetically Modified CD20-Specific CD8+ Cytotoxic T Lymphocytes

Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies

GMP Documentation

Induction of lymphokine-activated killer activity by interleukin 4 in human lymphocytes preactivated by interleukin 2 in vivo or in vitro

Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients

Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects

The effects of pentoxifylline on the generation of human lymphokine-activated killer cell cytotoxicity

Impaired in vivo and in vitro antibody responses to bacteriophage phi X 174 in juvenile rheumatoid arthritis

Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma

Prolonged continous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma

Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells

Outcome after acute ischemic stroke is linked to sex-specific lesion patterns

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

Suchergebnisse filtern